Financials

  • Market Capitalization 353.61 M
  • Employee 161
  • Founded 2018
  • CEO N/A
  • Website www.lyell.com
  • Headquarter Delaware, United States
  • FIGI BBG00RNXFN14
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-1.11
Fiyat/satışlar oranı
9 792.6

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
3136
IPSC
Century Therapeutics, Inc. - Common Stock
2.04 USD+0.49%-3.32%-0.49%+316.33%369.39 M USD
3165
FHTX
Foghorn Therapeutics Inc. - Common Stock
5.81 USD-3.17%-16.04%+27.69%+42.40%345.03 M USD
3185
PALI
Palisade Bio, Inc. - Common Stock
1.96 USD-2.00%-4.39%+3.16%+15.29%341.57 M USD
3199
SABS
SAB Biotherapeutics, Inc. - Common Stock
3.77 USD-0.53%+1.34%+5.01%+83.01%343.02 M USD

Haberler